Siegfried Holding AG
SFZN | SW
Overview
Corporate Details
- ISIN(s):
- CH0014284498 (+3 more)
- LEI:
- 506700J9QD6IF3937W06
- Country:
- Switzerland
- Address:
- Untere Brühlstrasse 4, 4800 Zofingen
- Sector:
- Health Care
- Industry:
- Health Care Providers & Services
Description
As an internationally recognized outsourcing partner, Siegfried provides products and tailor made services that integrate seamlessly into a customers value chain. The company offers pharmaceutical industry partners a comprehensive range of services, from development of drug substances to product development, registration and manufacturing to packaging and logistics. Once a fully integrated pharmaceutical company, Siegfried is one of the few suppliers today that can provide both the drug substance and the drug product development and production capabilities. This combination of know-how and experience is unique for a supplier of development and production services. Siegfried has expanded its technology base and geographic presence around the world in the past years. In addition to technological competence and a global presence, full compliance for all products and work processes to ensure safety is a high priority.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-23 06:30 |
Regulatory News Service
Siegfried expands production capacity for ophthalmic drugs in El Masnou
|
English | 18.6 KB | |
| 2025-05-23 02:00 |
Regulatory News Service
Siegfried expands production capacity for ophthalmic drugs in El Masnou
|
English | 13.7 KB | |
| 2025-04-10 15:30 |
Declaration of Voting Results & Voting Rights Announcements
Siegfried shareholders approve all proposals at Annual General Meeting 2025
|
English | 19.4 KB | |
| 2025-02-18 01:00 |
Earnings Release
Siegfried reports continued profitable growth fueled by strong underlying busin…
|
English | 19.1 KB | |
| 2024-12-24 06:30 |
Regulatory News Service
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
|
English | 15.8 KB | |
| 2024-12-23 06:30 |
Regulatory News Service
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
|
English | 15.8 KB | |
| 2024-12-23 01:00 |
Regulatory News Service
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
|
English | 12.1 KB | |
| 2024-12-07 06:30 |
Board/Management Change
Changes in Siegfried's senior management team
|
English | 17.7 KB | |
| 2024-12-06 06:30 |
Board/Management Change
Changes in Siegfried's senior management team
|
English | 17.7 KB | |
| 2024-12-06 01:00 |
Board/Management Change
Changes in Siegfried's senior management team
|
English | 14.0 KB | |
| 2024-11-19 06:30 |
Regulatory News Service
Siegfried opens new global R&D Center for Drug Substances in Evionnaz
|
English | 12.6 KB | |
| 2024-11-19 01:00 |
Regulatory News Service
Siegfried opens new global R&D Center for Drug Substances in Evionnaz
|
English | 9.9 KB | |
| 2024-11-12 06:30 |
Regulatory News Service
DINAMIQS opens new lab in Zurich
|
English | 14.1 KB | |
| 2024-11-12 01:00 |
Regulatory News Service
DINAMIQS opens new lab in Zurich
|
English | 11.4 KB | |
| 2024-10-24 06:30 |
Regulatory News Service
Strategy EVOLVE+ paves the way for continued profitable growth
|
English | 16.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-10-31 | N/A | Executive member | Sell | None | 1,695,000.00 CHF |
| 2024-10-31 | N/A | Executive member | Sell | None | 1,584,260.00 CHF |
| 2024-08-28 | N/A | Executive member | Sell | None | 1,086,000.00 CHF |
| 2024-08-28 | N/A | Executive member | Sell | None | 380,100.00 CHF |
| 2024-08-28 | N/A | Executive member | Sell | None | 362,724.00 CHF |
| 2024-06-14 | N/A | Non-Executive member | Sell | None | 368,930.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 4,587,500.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 1,376,250.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 917,500.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 458,750.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
International Care Company | Italy | ICC | |
|
IVF HARTMANN Holding AG | Switzerland | VBSN | |
|
M1 Kliniken AG | Germany | M12 | |
|
Medard Spolka Akcyjna | Poland | MRD | |
|
Mlp Saglik Hizmetleri AS | Türkiye | MPARK | |
|
Nordhealth AS | Norway | NORDH | |
|
Omda AS | Norway | CSAM | |
|
OPTIBIOTIX HEALTH PLC | United Kingdom | OPTI | |
|
OPTIMA HEALTH PLC | United Kingdom | OPT | |
|
Qiagen N.V. | Netherlands (Kingdom of the) | QIA |